Hans Helmerich
Known title: DirectorCIK: 0001196793
Associated companies
Transaction History
| HP | ▼ Sell | Open Market | 25,000 | $1.1M | 8/20/2026 | View on chart |
| HP | ▼ Sell | Open Market | 65,000 | $2.9M | 8/20/2026 | View on chart |
| HP | ▼ Sell | Open Market | 4,470 | $196K | 8/20/2026 | View on chart |
| HP | ▲ Buy | Grant | 7,910 | $0 | 3/5/2026 | View on chart |
| HP | ▼ Sell | Open Market | 25,000 | $703K | 12/19/2025 | View on chart |
| HP | ▼ Sell | Open Market | 50,000 | $1.4M | 12/19/2025 | View on chart |
| HP | ▲ Buy | Grant | 10,765 | $0 | 3/6/2025 | View on chart |
| HP | ▲ Buy | Grant | 7,012 | $0 | 2/28/2024 | View on chart |
| HP | ▼ Sell | Gift | 2,990 | $0 | 12/15/2023 | View on chart |
| HP | ▼ Sell | Open Market | 74,373 | $3.2M | 9/27/2023 | View on chart |
| HP | ▼ Sell | Open Market | 25,627 | $1.1M | 9/26/2023 | View on chart |
| HP | ▲ Buy | Grant | 6,296 | $0 | 3/1/2023 | View on chart |
| HP | ▼ Sell | Gift | 10,000 | $0 | 12/2/2022 | View on chart |
| HP | ▼ Sell | Open Market | 7,500 | $375K | 12/1/2022 | View on chart |
| HP | ▼ Sell | Open Market | 3,000 | $150K | 12/1/2022 | View on chart |
| HP | ▼ Sell | Open Market | 50,000 | $2.1M | 3/10/2022 | View on chart |
| HP | ▼ Sell | Open Market | 100,000 | $4.3M | 3/10/2022 | View on chart |
| HP | ▲ Buy | Grant | 7,099 | $0 | 3/2/2022 | View on chart |
| HP | ▼ Sell | Gift | 100,000 | $0 | 11/24/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Susquehanna Raises Helmerich & Payne Price Target to $50
Susquehanna has maintained a positive outlook on Helmerich & Payne and raised its price target to $50. This move places the firm at the top of the current analyst consensus range, which averages $44.75. The stock is currently trading near its 200-day moving average, with the new target sitting above the recent 52-week high.
Susquehanna Raises Helmerich & Payne Price Target to $50. Susquehanna has maintained a positive outlook on Helmerich & Payne and raised its price target to $50. This move places the firm at the top of the current analyst consensus range, which averages $44.75. The stock is currently trading near its 200-day moving average, with the new target sitting above the recent 52-week high.